Alnylam Pharmaceuticals, Inc. (ALNY) Misses Q3 EPS by 9c

November 6, 2013 4:01 PM

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) reported Q3 EPS of ($0.48) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found